Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Total Current Liabilities: 2009-2024

Historic Total Current Liabilities for Fresenius Medical Care AG (FMS) over the last 17 years, with Q3 2025 value amounting to $6.7 billion.

  • Fresenius Medical Care AG's Total Current Liabilities rose 410.68% to $6.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 billion, marking a year-over-year increase of 410.68%. This contributed to the annual value of $6.1 billion for FY2024, which is 683.74% down from last year.
  • As of Q3 2025, Fresenius Medical Care AG's Total Current Liabilities stood at $6.7 billion, which was up 410.68% from $6.4 billion recorded in Q2 2025.
  • Fresenius Medical Care AG's Total Current Liabilities' 5-year high stood at $8.9 billion during Q2 2021, with a 5-year trough of $5.7 billion in Q1 2025.
  • In the last 5 years, Fresenius Medical Care AG's Total Current Liabilities had a median value of $6.7 billion in 2024 and averaged $7.1 billion.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first surged by 1498.09% in 2021, then crashed by 2745.25% in 2022.
  • Fresenius Medical Care AG's Total Current Liabilities (Quarter) stood at $8.3 billion in 2021, then dropped by 20.53% to $6.6 billion in 2022, then decreased by 0.34% to $6.6 billion in 2023, then decreased by 8.02% to $6.0 billion in 2024, then rose by 11.32% to $6.7 billion in 2025.
  • Its last three reported values are $6.7 billion in Q3 2025, $6.4 billion for Q2 2025, and $5.7 billion during Q1 2025.